Red Tree Management, LLCFirm match from fund name (lower confidence)
Red Tree Venture Fund II, L.P.
Open: first sale Jan 2024, per Form D (fund age approximates vintage)
- Vintage
- 2024
- Fund size
- $133.27M to $350M (Form D)
- Stages
- Seed, Series A
- Sectors
- Biotech, Medical devices
- Regions
- CA, OR, WA
01 · Thesis
Red Tree Venture Capital is an early stage-biased life science venture firm. It invests in first-in-class and best-in-class therapeutics in oncology, neurology, and immunology, and selectively funds medical device companies. It sources deals from West Coast academic and research institutions and often leads or co-leads rounds.Inferred from the firm's website
02 · Initial check
$1.33M to $5.83M (estimated from fund size)
Estimated from Form D: $133.27M sold of a $350M target
03 · Who to approach
Named on this fund's Form D
- Heath Lukatch, Ph.D., Co-Founder and Managing Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideRed Tree Venture Capital is an early stage-biased life science venture firm focused on therapeutics in oncology, neurology, and immunology, with selective medical device investments.
Red Tree Venture Capital is an early stage-biased life science venture firm
https://redtreevc.com/about-us/
06 · Sources
Last verified: Oct 28, 2026